Author:
MAUSER-BUNSCHOTEN E. P.,KLEINE BUDDE I.,LOPACIUK S.,KOOPMAN M. M. W.,Van Der MEER F. J. M.,NOVÀKOVÀ I. R. O.,YPMA P.,Van Der LINDEN P. W. G.,WINDYGA J.,STRENGERS P. F. W.
Subject
Genetics(clinical),Hematology,General Medicine
Reference20 articles.
1. Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity;Gray;Thromb Haemost,1995
2. Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products;Foster;Vox Sang,2000
3. Factor VIII and transmissible spongiform encephalopathy: the case for safety;Cervenakova;Haemophilia,2002
4. Scrapie removal using Planova virus removal filters;Tateishi;Biologicals,2001
5. The European Agency for the Evaluation of Medicinal Products CPMP 198/95, Final: ‘Note for guidance to assess efficacy and safety of human plasma derived Factor VIII:C and Factor IX:C products in clinical trials in haemophiliacs before and after authorisation’ 1996
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献